Procter & Gamble vs Roche: Founders, CEOs and History
Procter & Gamble was founded in 1837 by William Procter, James Gamble and is led by Shailesh Jejurikar. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.
Company facts
Procter & Gamble
- Founded
- 1837
- Headquarters
- Cincinnati, Ohio, United States
- Current CEO
- Shailesh Jejurikar
- Employees
- 109,000
Roche
- Founded
- 1896
- Headquarters
- Basel, Switzerland
- Current CEO
- Thomas Schinecker
- Employees
- 112,774
Founders
Procter & Gamble
William Procter
William Procter was an English-born candlemaker who settled in Cincinnati, Ohio, and built a candle-making business there. In 1837, on the advice of his father-in-law, he went into partnership with his brother-in-law James Gamble to form Procter & Gamble.
James Gamble
James Gamble was an Irish-born soap maker in Cincinnati who joined William Procter in 1837 to form Procter & Gamble. He concentrated on soap formulation and efficient production, and the company later launched Ivory Soap, known for floating in water.
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
CEOs and their tenures
Procter & Gamble
- Jon Moeller2021–2026
Chief Executive Officer; later Executive Chairman
As CFO and later CEO, he successfully stabilized P&G's declining revenue by enforcing strict pricing power during severe global inflation.
Source - Andre Schulten2021–present
Chief Financial Officer
As CFO, he maintained the company's industry-leading gross margins and managed the complex financial exit from the Russian market in 2022.
Source - Shailesh Jejurikar2026–present
President and CEO
Mumbai-born P&G veteran of more than 37 years who previously led Fabric & Home Care and served as Chief Operating Officer.
Source
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Timeline: Procter & Gamble and Roche side by side
1837Procter & Gamble
Company Founded in Cincinnati
William Procter and James Gamble sign a partnership agreement on October 31, 1837, establishing Procter & Gamble in Cincinnati, Ohio, with combined capital of approximately 7,192 dollars.
1862Procter & Gamble
Civil War Army Contracts Fuel Expansion
P&G wins contracts to supply the Union Army with soap and candles, generating significant revenue that enables manufacturing expansion and introduces millions of American soldiers to P&G products for the first time.
1882Procter & Gamble
Ivory Soap Launches Nationally
Harley Procter and James Norris Gamble introduce Ivory soap, promoted as 99 and 44/100 percent pure and notable for its floating characteristic.
1890Procter & Gamble
Company Incorporates and Expands Nationally
Procter & Gamble incorporates in Ohio with capital of 4.5 million dollars and begins building manufacturing capacity outside Cincinnati, establishing the operational infrastructure for national distribution that the Ivory soap advertising campaign had created…
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1911Procter & Gamble
Crisco Shortening Introduced
P&G launches Crisco vegetable shortening, the first hydrogenated vegetable oil product marketed to American consumers as an alternative to lard and butter.
1931Procter & Gamble
Brand Management System Invented
P&G executive Neil McElroy writes a famous internal memo proposing that each brand have its own dedicated management team responsible for competing against all rivals including other P&G brands.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1946Procter & Gamble
Tide Detergent Launches
P&G introduces Tide synthetic detergent, which rapidly becomes the best-selling laundry product in the United States and establishes the template for all future P&G brand development: superior product performance, heavy consumer advertising, and sustained mark…
1961Procter & Gamble
Pampers Diapers Introduced
P&G introduces Pampers disposable diapers, transforming the infant care category and creating what will become one of the company's most globally significant brands.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
2005Procter & Gamble
Gillette Acquired for 57 Billion Dollars
P&G completes the acquisition of Gillette Company for approximately 57 billion dollars in an all-stock transaction, adding Gillette razors, Braun appliances, Oral-B dental products, and Duracell batteries to the P&G portfolio.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2014Procter & Gamble
Portfolio Transformation Announced
CEO A.G. Lafley announces P&G's plan to divest more than 100 brands and focus the company on approximately 80 core brands in ten product categories.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2019Procter & Gamble
Portfolio Simplification Completed
P&G completes the brand portfolio simplification, having divested more than 100 brands and consolidated around approximately 65 core brands.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2024Procter & Gamble
Fiscal Year 2024 Net Sales Reach Approximately 84 Billion Dollars
P&G reports fiscal year 2024 net sales of $84.0 billion and net earnings attributable to P&G of about $14.9 billion, and raises its quarterly dividend 7% to $1.0065 per share, its 68th consecutive annual increase.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
Acquisitions
Procter & Gamble
- Gillette2005$57B
- Gillette2005Undisclosed
- Richardson-Vicks1985$1.2B
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Questions about Procter & Gamble vs Roche
Who is the CEO of The Procter & Gamble Company and F. Hoffmann-La Roche AG?
The Procter & Gamble Company is led by Shailesh Jejurikar and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was The Procter & Gamble Company founded vs F. Hoffmann-La Roche AG?
The Procter & Gamble Company was founded in 1837 — 59 years before F. Hoffmann-La Roche AG, which was founded in 1896. The Procter & Gamble Company's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger F. Hoffmann-La Roche AG.
How many employees does The Procter & Gamble Company have compared to F. Hoffmann-La Roche AG?
The Procter & Gamble Company employs approximately 109,000 people, while F. Hoffmann-La Roche AG employs approximately 112,774. F. Hoffmann-La Roche AG has the larger workforce at 112,774 employees, compared to The Procter & Gamble Company's 109,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are The Procter & Gamble Company and F. Hoffmann-La Roche AG headquartered?
The Procter & Gamble Company is headquartered in United States and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded The Procter & Gamble Company and F. Hoffmann-La Roche AG?
The Procter & Gamble Company was founded by William Procter, James Gamble. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.
Which company has a longer operating history — The Procter & Gamble Company or F. Hoffmann-La Roche AG?
The Procter & Gamble Company has been operating for approximately 189 years, making it the more established of the two companies. F. Hoffmann-La Roche AG has been in operation for around 130 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Procter & Gamble vs Roche overview